#2421 - Derek, More Plates More Dates

Bullish:

• $GORILLA - Gorilla Mind is expanding retail distribution into major chains like GNC, Vitamin Shoppe, and Circle K, indicating strong business growth for the nootropics company

  • “This is kinda like the fine balance of what I thought to be the most sustainable version of balancing, you know, dopamine input, serotonergic activity, getting some of that, you know, antianxiety support, and also getting a reasonable hit of caffeine.”

    Derek·7:49

  • “We're in GNC's, vitamin shops across the country. We're gonna be in Circle K soon and soon to be more spots, hopefully.”

    Derek·3:02:32
• $GLP1 - Pharmaceutical companies are developing innovations to address muscle loss side effects of GLP-1 drugs like semaglutide, potentially expanding the market

  • “Pharmaceutical pipelines are trying to integrate them in order to offset muscle catabolism induced via GLP one agonist, semaglutide.”

    Derek·2:36:08
• $HRT - FDA removal of black box warnings on women's hormone replacement therapy products could significantly expand this market

  • “This past month, the FDA actually removed the most of the black box warnings off of women's HRT products.”

    Derek·1:09:25
• $PEPTIDES - Gene therapies and peptide therapeutics are emerging biotechnologies with innovation potential despite current efficacy limitations

  • “There is gene therapies that are being utilized now. They're just not that efficacious.”

    Derek·2:36:08

Bearish:

• $BODYBUILDING - Increased education about genetic limitations and health risks is affecting participation in bodybuilding

  • “I think fortunately, that's part of where the education comes in is back in the day, you wouldn't know that you had the bad genetics.”

    Derek·2:34:46